The FDA Law Blogs argument is simple: the policy environment is shifting, but its shifting incrementally
Editorial refresh Practical 2026 note for BPC BPC now carries extra 2026 context around BPC-157, bpc, 157, sermorelin, which, better, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation
A short neuropeptide, a copper-binding peptide, a GLP-1 analog, and a growth-hormone secretagogue should not be treated as identical just because they are all sold in vials
Because the treatment delivers nutrients directly into the bloodstream, absorption is far more complete than anything a cream can achieve through the skin barrier, which translates to more even brightening from within